Cancer risk associated with chronic diseases and disease markers: prospective cohort study
- PMID: 29386192
- PMCID: PMC5791146
- DOI: 10.1136/bmj.k134
Cancer risk associated with chronic diseases and disease markers: prospective cohort study
Abstract
Objectives: To assess the independent and joint associations of major chronic diseases and disease markers with cancer risk and to explore the benefit of physical activity in reducing the cancer risk associated with chronic diseases and disease markers.
Design: Prospective cohort study.
Setting: Standard medical screening program in Taiwan.
Participants: 405 878 participants, for whom cardiovascular disease markers (blood pressure, total cholesterol, and heart rate), diabetes, chronic kidney disease markers (proteinuria and glomerular filtration rate), pulmonary disease, and gouty arthritis marker (uric acid) were measured or diagnosed according to standard methods, were followed for an average of 8.7 years.
Main outcome measures: Cancer incidence and cancer mortality.
Results: A statistically significantly increased risk of incident cancer was observed for the eight diseases and markers individually (except blood pressure and pulmonary disease), with adjusted hazard ratios ranging from 1.07 to 1.44. All eight diseases and markers were statistically significantly associated with risk of cancer death, with adjusted hazard ratios ranging from 1.12 to 1.70. Chronic disease risk scores summarizing the eight diseases and markers were positively associated with cancer risk in a dose-response manner, with the highest scores associated with a 2.21-fold (95% confidence interval 1.77-fold to 2.75-fold) and 4.00-fold (2.84-fold to 5.63-fold) higher cancer incidence and cancer mortality, respectively. High chronic disease risk scores were associated with substantial years of life lost, and the highest scores were associated with 13.3 years of life lost in men and 15.9 years of life lost in women. The population attributable fractions of cancer incidence or cancer mortality from the eight chronic diseases and markers together were comparable to those from five major lifestyle factors combined (cancer incidence: 20.5% v 24.8%; cancer mortality: 38.9% v 39.7%). Among physically active (versus inactive) participants, the increased cancer risk associated with chronic diseases and markers was attenuated by 48% for cancer incidence and 27% for cancer mortality.
Conclusions: Chronic disease is an overlooked risk factor for cancer, as important as five major lifestyle factors combined. In this study, chronic diseases contributed to more than one fifth of the risk for incident cancer and more than one third of the risk for cancer death. Physical activity is associated with a nearly 40% reduction in the cancer risk associated with chronic diseases.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Individual and Combined Associations of Modifiable Lifestyle and Metabolic Health Status With New-Onset Diabetes and Major Cardiovascular Events: The China Cardiometabolic Disease and Cancer Cohort (4C) Study.Diabetes Care. 2020 Aug;43(8):1929-1936. doi: 10.2337/dc20-0256. Epub 2020 Jun 15. Diabetes Care. 2020. PMID: 32540923
-
Associations of Lifestyle and Genetic Risks with Obesity and Related Chronic Diseases in the UK Biobank: A Prospective Cohort Study.Am J Clin Nutr. 2024 Jun;119(6):1514-1522. doi: 10.1016/j.ajcnut.2024.04.025. Epub 2024 Apr 25. Am J Clin Nutr. 2024. PMID: 38677521
-
Physical activity trajectories and mortality: population based cohort study.BMJ. 2019 Jun 26;365:l2323. doi: 10.1136/bmj.l2323. BMJ. 2019. PMID: 31243014 Free PMC article.
-
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.Lancet Diabetes Endocrinol. 2014 Aug;2(8):634-47. doi: 10.1016/S2213-8587(14)70102-0. Epub 2014 May 16. Lancet Diabetes Endocrinol. 2014. PMID: 24842598 Free PMC article. Review.
-
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210. Health Technol Assess. 2010. PMID: 20441712 Review.
Cited by
-
Using a Bayesian analytic approach to identify county-level ecological factors associated with survival among individuals with early-onset colorectal cancer.PLoS One. 2024 Oct 29;19(10):e0311540. doi: 10.1371/journal.pone.0311540. eCollection 2024. PLoS One. 2024. PMID: 39471191 Free PMC article.
-
Association between gout and cancers: A systematic review and meta-analysis.Medicine (Baltimore). 2024 Oct 25;103(43):e40234. doi: 10.1097/MD.0000000000040234. Medicine (Baltimore). 2024. PMID: 39470515 Free PMC article.
-
Novel multi-omics deconfounding variational autoencoders can obtain meaningful disease subtyping.Brief Bioinform. 2024 Sep 23;25(6):bbae512. doi: 10.1093/bib/bbae512. Brief Bioinform. 2024. PMID: 39413796 Free PMC article.
-
Cancer and Heart Failure: Dangerous Liaisons.J Cardiovasc Dev Dis. 2024 Aug 27;11(9):263. doi: 10.3390/jcdd11090263. J Cardiovasc Dev Dis. 2024. PMID: 39330321 Free PMC article. Review.
-
Association of the systemic inflammation and anthropometric measurements with cancer risk: a prospective study in MJ cohort.Front Oncol. 2024 Sep 9;14:1400893. doi: 10.3389/fonc.2024.1400893. eCollection 2024. Front Oncol. 2024. PMID: 39314636 Free PMC article.
References
-
- GBD 2015 Mortality and Causes of Death Collaborators Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1459-544. 10.1016/S0140-6736(16)31012-1. - DOI - PMC - PubMed
-
- GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117-71. 10.1016/S0140-6736(14)61682-2. - DOI - PMC - PubMed
-
- Stewart BW, Kleihues P (Eds). World Cancer Report 2014. IARCPress. Lyon 2014.
-
- Cancer Control: Knowledge into Action: WHO Guide for Effective Programmes: Module 2: Prevention. Geneva: World Health Organization 2007. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical